The MS Bioscreen - Translational Digital Medicine for Multiple Sclerosis

Investigator: Stephen L. Hauser, MD
Sponsor: Conrad N. Hilton Foundation

Location(s): United States


Multiple sclerosis (MS) is a complex neurological disease with symptoms that vary from one person to the next, and over each patient's lifetime. An increasingly difficult challenge for clinicians and patients is to organize, integrate and interpret diverse types of clinical and biologic data to track disease processes, predict outcomes, and personalize therapeutic decision-making. 

Scientists and clinicians at UCSF are developing a powerful new tool for MS patients and their health care providers. The MS Bioscreen is designed to access and integrate your medical records with the latest population-based data, making it possible to chart a unique course of treatment for you.

Using state-of-the-art information technology, the MS Bioscreen applies a highly secure database gateway and proprietary comparative and predictive algorithms to compare your data with a cloud-based longitudinal collection of data from hundreds of other MS patients, including 3D MRI scans. You and your doctor can use this vast collection of information to help guide your decisions.

The investigators would like to release the MS Bioscreen as a tool to deliver precision medicine to all MS patients worldwide. If you would like to be notified when the app is available, or if you would like to help, please contact Pierre-Antoine Gourraud, PhD.